Home / Science / Health /  Pfizer-BioNTech Covid-19 booster shot was 95.6% effective in large trial, companies say

A third dose of the Covid-19 vaccine from Pfizer Inc. and BioNTech SE was found in a large study to be highly protective against symptomatic Covid-19, the companies said Thursday.


Recommended For You

Edit Profile
Get alerts on WhatsApp
Set Preferences My ReadsWatchlistFeedbackRedeem a Gift CardLogout